Latest Period
Q1 2026
Security Snapshot
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) Institutional Ownership
CUSIP: 59503A204
13F Institutional Holders and Ownership History from Q3 2018 to Q1 2026
Institutions Reporting
79
Shares (Excl. Options)
14,237,368
Price
$2.41
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.01 per share
- Symbol
- MBOT on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 14,237,368
- Total 13F value
- $34,312,219
- Portfolio coverage rank
- 0%
- Share change
- +4,257,780
- Value change
- +$10,353,067
- Number of holders
- 79
- Shares outstanding
- 73,197,378
- SEC-reported price per share
- $2.17
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share is tracked under CUSIP 59503A204.
- 79 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 71 to 79 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $22,844,684 to $34,312,219.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 79 institutions filings for Q1 2026.
Security key
59503A204
Latest holder period
Q1 2026
13F holders
79
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
MBOT full holder history
Microbot Medical Inc. SEC filings
Microbot Medical Inc. company facts
Microbot Medical Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 59503A204:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
MBOT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC | 8.2% | $12,004,370 | +$12,004,370 | 6,002,185 | Mitchell P. Kopin | 15 Jan 2026 | ||
| VANGUARD GROUP INC | 4.4% | -20% | $7,147,861 | +$893,415 | 2,343,561 | +14% | The Vanguard Group | 30 Sep 2025 |
| CVI Investments, Inc. | 4.9% | -20% | $4,780,994 | +$1,487,280 | 1,824,807 | +45% | CVI Investments, Inc. | 31 Mar 2025 |
As of 31 Mar 2026, 79 institutional investors reported holding 14,237,368 shares of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT). This represents 19% of the company’s total 73,197,378 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
18%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 2,909,525 | 0% | 0% | $7,011,955 |
| CIBC Bancorp USA Inc. | 2.6% | 1,870,000 | 0.01% | $4,506,700 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.3% | 924,307 | -26% | 0% | $2,227,580 |
| BlackRock, Inc. | 1.2% | 857,398 | -1.3% | 0% | $2,066,329 |
| UBS Group AG | 1.1% | 816,945 | +84% | 0% | $1,968,837 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 760,831 | -0.15% | 0% | $1,834,463 |
| DNB Asset Management AS | 0.93% | 677,498 | 0% | 0.01% | $1,632,770 |
| STIFEL FINANCIAL CORP | 0.78% | 573,075 | +115% | 0% | $1,381,119 |
| MARSHALL WACE, LLP | 0.66% | 481,045 | 0% | $1,159,319 | |
| Ancora Advisors LLC | 0.65% | 477,080 | 0.02% | $1,149,763 | |
| MILLENNIUM MANAGEMENT LLC | 0.62% | 454,746 | +872% | 0% | $1,095,938 |
| VANGUARD FIDUCIARY TRUST CO | 0.55% | 400,225 | 0% | 0% | $964,542 |
| GOLDMAN SACHS GROUP INC | 0.42% | 309,103 | +797% | 0% | $744,938 |
| STATE STREET CORP | 0.41% | 303,569 | +47% | 0% | $731,601 |
| AlphaCentric Advisors LLC | 0.27% | 200,000 | 0% | 0.48% | $482,000 |
| Russell Investments Group, Ltd. | 0.27% | 198,622 | 0% | $478,678 | |
| 683 Capital Management, LLC | 0.23% | 170,000 | -34% | 0.04% | $409,700 |
| NORTHERN TRUST CORP | 0.2% | 143,360 | +26% | 0% | $345,498 |
| JANE STREET GROUP, LLC | 0.19% | 141,541 | -28% | 0% | $341,114 |
| Squarepoint Ops LLC | 0.17% | 125,593 | +412% | 0% | $302,679 |
| Hudson Bay Capital Management LP | 0.17% | 121,082 | 0% | $291,808 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.13% | 94,300 | -15% | 0% | $227,263 |
| OMERS ADMINISTRATION Corp | 0.12% | 85,500 | -41% | 0% | $206,055 |
| MORGAN STANLEY | 0.11% | 78,504 | +14% | 0% | $189,196 |
| BANK OF AMERICA CORP /DE/ | 0.1% | 75,799 | +1688% | 0% | $182,676 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
31
Latest
Q1 2026
Rows shown
1-25 of 31
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 14,237,368 | $34,312,219 | +$10,353,067 | $2.41 | 79 |
| 2025 Q4 | 11,422,467 | $22,844,684 | +$3,310,309 | $2.00 | 71 |
| 2025 Q3 | 9,849,602 | $30,051,548 | +$16,711,553 | $3.05 | 67 |
| 2025 Q2 | 4,386,909 | $11,055,709 | +$5,764,677 | $2.52 | 47 |
| 2025 Q1 | 2,156,269 | $3,255,605 | +$1,699,280 | $1.51 | 41 |
| 2024 Q4 | 1,103,488 | $1,235,663 | +$63,070 | $1.12 | 34 |
| 2024 Q3 | 1,044,132 | $933,420 | -$46,041 | $0.89 | 23 |
| 2024 Q2 | 1,085,208 | $1,107,053 | -$449,318 | $1.02 | 33 |
| 2024 Q1 | 1,447,970 | $1,768,115 | -$281,766 | $1.23 | 31 |
| 2023 Q4 | 1,519,532 | $2,490,748 | +$867,449 | $1.64 | 30 |
| 2023 Q3 | 1,000,057 | $1,398,056 | -$857,178 | $1.39 | 25 |
| 2023 Q2 | 1,236,959 | $3,364,899 | -$460,248 | $2.72 | 25 |
| 2023 Q1 | 1,415,902 | $2,944,553 | -$152,124 | $2.08 | 25 |
| 2022 Q4 | 1,488,966 | $4,481,066 | +$2,064,567 | $3.01 | 21 |
| 2022 Q3 | 803,086 | $3,837,000 | +$2,761 | $4.78 | 16 |
| 2022 Q2 | 702,489 | $3,605,000 | -$247,792 | $5.13 | 16 |
| 2022 Q1 | 741,045 | $4,646,000 | +$150,132 | $6.27 | 18 |
| 2021 Q4 | 812,545 | $6,094,000 | +$265,795 | $7.50 | 18 |
| 2021 Q3 | 777,709 | $5,467,007 | +$107,409 | $7.03 | 16 |
| 2021 Q2 | 754,563 | $5,992,008 | -$382,067 | $7.94 | 21 |
| 2021 Q1 | 794,962 | $6,765,734 | +$295,356 | $8.51 | 20 |
| 2020 Q4 | 766,370 | $5,280,007 | -$45,186 | $6.89 | 16 |
| 2020 Q3 | 772,286 | $5,931,008 | -$23,065 | $7.71 | 16 |
| 2020 Q2 | 682,819 | $4,718,007 | -$1,382,287 | $6.91 | 13 |
| 2020 Q1 | 701,275 | $3,888,006 | +$236,511 | $5.51 | 19 |